Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,458,089

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,458,089

Title:	Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents
Abstract:	The present invention relates to particular phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering biologically active agents to a target. These compounds are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.
Inventor(s):	Mustata; Gabriela (Roseland, NJ), Pan; Dahua (Roseland, NJ), Gschneidner; David (Roseland, NJ)
Assignee:	Emisphere Technologies, Inc. (Roseland, NJ)
Application Number:	14/423,319
Patent Claims:	see list of patent claims

Details for Patent 9,458,089

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	NEUPOGEN	filgrastim	VIAL	103353	001	1991-02-20	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
Amgen	NEUPOGEN	filgrastim	VIAL	103353	002	1991-02-20	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
Amgen	NEUPOGEN	filgrastim	SYRINGE	103353	003	1991-02-20	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
Amgen	NEUPOGEN	filgrastim	SYRINGE	103353	004	1991-02-20	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	➤ Sign Up	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,458,089

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
Australia	2013305664	Apr 09, 2015
Australia	2013305664	Feb 01, 2018
Brazil	112015003761	Jul 04, 2017
Canada	2882719	Feb 27, 2014
China	104703962	Jun 10, 2015
China	104703962	Nov 07, 2017
European Patent Office	2888224	Jul 01, 2015
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.